The impact of body mass index (BMI) on treatment outcome of targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Cancer Database Consortium.Laurence Albigès, Toni K. Choueiri, Wanling Xie et al.|Journal of Clinical Oncology|2014Cited by 8
Outcomes of metastatic chromophobe renal cell carcinoma (chrRCC) in the targeted therapy era: Results from the International Metastatic Renal Cell Cancer Database Consortium.Steven Yip, Daniel Yick Chin Heng, José Manuel Ruiz Morales et al.|Journal of Clinical Oncology|2016Cited by 1
Local treatments and TKI efficacy in radioiodine refractory differentiated thyroid carcinoma patients: a single center experienceKaterina Saltiki, Maria Alevizaki, Olga Karapanou et al.|Endocrine Related Cancer|2025Cited by 1